Virodhamine trifluoroacetate is an antagonist of endogenous cannabinoid receptor mixed that acts by being a full agonist at GPR55 and CB2 and partial antagonist at CB1.

1415264-56-0

C24H38F3NO4

461.56

Virodhamine trifluoroacetate salt;Virodhamine-trifluoroacetate;Virodhamine trifluoroacetate

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years